Boston Financial Statements From 2010 to 2024

Stocks UK . 
Stock . Boston Scientific Corp
0HOY Stock   89.66  0.22  0.25%   
Boston Scientific financial statements provide useful quarterly and yearly information to potential Boston Scientific Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Boston Scientific financial statements helps investors assess Boston Scientific's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Boston Scientific's valuation are summarized below:
Gross Profit
8.7 B
Quarterly Earnings Growth
(0.06)
Profit Margin
0.1126
Revenue
15.9 B
Earnings Share
0.53
There are over seventy-six available fundamental signals for Boston Scientific Corp, which can be analyzed over time and compared to other ratios. All traders should validate Boston Scientific's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Boston Scientific Total Revenue

10.62 Billion

Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 B, Total Revenue of 10.6 B or Gross Profit of 6.9 B, as well as many indicators such as . Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
This module can also supplement various Boston Scientific Technical models . Check out the analysis of Boston Scientific Correlation against competitors.

Boston Scientific Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26.4 B35.1 B23.3 B
Slightly volatile
Other Current Liabilities2.8 B3.2 B2.4 B
Slightly volatile
Total Current Liabilities4.1 B4.9 B3.5 B
Slightly volatile
Total Stockholder Equity12 B19.3 B10.5 B
Slightly volatile
Property Plant And Equipment Net2.3 B3.3 B2 B
Slightly volatile
Accounts Payable543.4 M942 M462.4 M
Slightly volatile
Cash927.8 M865 M764.2 M
Slightly volatile
Non Current Assets Total21.4 B28.6 B18.9 B
Slightly volatile
Other Assets5.5 B5.3 B2.2 B
Slightly volatile
Cash And Short Term Investments928.1 M865 M764.5 M
Slightly volatile
Net Receivables1.7 B2.2 B1.5 B
Slightly volatile
Good Will9.6 B14.4 B8.4 B
Slightly volatile
Common Stock Shares Outstanding1.5 B1.5 B1.4 B
Slightly volatile
Non Current Liabilities Total9.8 B10.7 B8.4 B
Slightly volatile
Inventory1.5 B2.5 B1.3 B
Slightly volatile
Other Current Assets949.8 M937 M849.3 M
Slightly volatile
Other Stockholder Equity17.8 B18.4 B16.2 B
Slightly volatile
Total Liabilities14.4 B15.6 B12.8 B
Slightly volatile
Total Current Assets5 B6.5 B4.3 B
Slightly volatile
Intangible Assets6.8 B6 B6.3 B
Pretty Stable
Common Stock17.9 M19.6 M16.4 M
Slightly volatile
Short and Long Term Debt Total8.1 B9.6 B6.8 B
Slightly volatile
Short Term Investments157 M149.5 M90.2 M
Slightly volatile
Liabilities And Stockholders Equity27.1 B35.1 B23.2 B
Slightly volatile
Short Term Debt711.3 M607 M522.2 M
Slightly volatile
Long Term Debt7 B10.5 B6.7 B
Slightly volatile
Capital Surpluse19.5 B22.7 B18.2 B
Slightly volatile
Property Plant Equipment2.4 B3.3 B2.1 B
Slightly volatile
Other Liabilities1.9 B1.6 B2.4 B
Slightly volatile
Current Deferred Revenue214.7 M266 M165.8 M
Slightly volatile

Boston Scientific Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1 B1.2 B888.7 M
Slightly volatile
Total Revenue10.6 B14.2 B9.4 B
Slightly volatile
Gross Profit6.9 B9.8 B6.1 B
Slightly volatile
Other Operating Expenses9.8 B11.9 B9.3 B
Pretty Stable
Operating Income1.5 B2.3 B1.4 B
Slightly volatile
EBIT1.5 B2.4 B1.3 B
Slightly volatile
Research Development1.2 B1.4 B1 B
Slightly volatile
EBITDA2.5 B3.6 B2.2 B
Slightly volatile
Cost Of Revenue3.7 B4.4 B3.3 B
Slightly volatile
Total Operating Expenses4.4 B7.5 B5.9 B
Slightly volatile
Interest Income253.1 M306.9 M320 M
Very volatile
Selling General Administrative4.1 B5 B3.7 B
Slightly volatile

Boston Scientific Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation163.3 M233 M144 M
Slightly volatile
Begin Period Cash Flow898.8 M1.1 B749.2 M
Slightly volatile
Depreciation1 B1.2 B888.7 M
Slightly volatile
Capital Expenditures428.8 M711 M370.6 M
Slightly volatile
Total Cash From Operating Activities1.5 B2.5 B1.4 B
Slightly volatile
End Period Cash Flow967 M1.1 B795.3 M
Slightly volatile

Boston Fundamental Market Drivers

Cash And Short Term Investments865 M

About Boston Scientific Financial Statements

Boston Scientific shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Boston Scientific investors may analyze each financial statement separately, they are all interrelated. The changes in Boston Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses on on Boston Scientific's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue266 M214.7 M
Total Revenue14.2 B10.6 B
Cost Of Revenue4.4 B3.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY